Versantis raises CHF 4,4 million in series a financing to advance new generation of liver disease medicines

by Healthequity

Versantis, a pharmaceutical company focused on the development of products addressing a high unmet medical need in the diagnosis, prevention, and treatment of liver diseases, today announces the closi...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

10 claves básicas para internacionaliza...

by Alitara Service Consultancy

La necesidad de comprender los entresijos de los mercados internaciona...

Photos Stream